AG VenturesQ2 FY24

AG Ventures Q2 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: 135.95P/E: 6.0Market Cap: ₹136 CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4
  • The company expects volume growth to be better in H2 FY '24 compared to H1, aiming to improve upon Q2 sales quantities.
  • They target increasing global market share from current 10% to 12% by end of calendar year 2024, driven by expansion in North America, new customers, and increased domestic market share.
  • Plans to fully utilize current capacities over the next 2-3 years before considering further expansion.
  • Domestic market demand is expected to grow robustly due to automotive industry growth, increased use of commercial vehicles, radialization of commercial tires, and government infrastructure projects.
  • They aim for flattish to positive volume growth for full FY '24 compared to FY '23, hoping not to be down overall.
  • Capacity utilization is expected to improve with appropriate allocations, which were a bottleneck previously.
  • Limited capacity additions expected in the near term, with only a Japanese competitor planning a 10,000 MT expansion.

See what AG Ventures management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • There is no explicit mention of any current or planned new fundraising through debt or equity in the transcript.
  • The company has focused on reducing debt by prepaying INR25.5 crores in the first half of FY '24 and expects to reduce further by about INR10.5 crores by the end of the year.
  • Long-term debt has already decreased from INR104.09 crores at the beginning of the year to INR78.5 crores as of September 30, 2023.
  • No announcements or discussions related to raising additional funds through equity or fresh debt were made during the call.
  • The management emphasizes utilizing current capacities and improving market share rather than expansion through fresh capital at this stage.

See what AG Ventures management said on order book — free account, 30 seconds.

Capex plans

Yes
- No new orders have been received for the recent capacity expansion, so there is no immediate ramp-up planned. - The company aims to increase capacity utilization of existing capacities first over the next 2-3 years before considering further expansion. - A Japanese competitor has declared a 10,000 metric tons capacity expansion plan, but no other players, including Flexsys, have indicated capacity expansion to OCCL's knowledge. - Management hopes that demand growth and geopolitical stability will ease pressure on capacity utilization, limiting the need for immediate expansion. - The company has approvals in place to sell out its entire current capacity but depends on allocations to achieve that. Overall, OCCL is focusing on better utilization of existing capacity before making new capital investments.

Track AG Ventures — get its next earnings analysis in your feed

Margin guidance

Category 3
  • The company aims to grow its global market share from 10% to 12% by the end of calendar year 2024.
  • Volume growth of around 15%-20% is expected in the second half of FY '24 after a 10% decline in the first half.
  • The domestic market is anticipated to grow robustly due to automotive industry growth, radialization of commercial tires, and infrastructure projects.
  • Current capacity utilization is expected to improve with better global demand, and further capacity expansions will be considered after full utilization.
  • Management hopes that realization levels have bottomed out and will stabilize, supporting margin sustainability.
  • Debt reduction efforts have been successful, with long-term debt expected to reduce further, positively impacting profitability.
  • EBITDA and PAT showed 10% and 9% growth year-on-year in H1 FY '24 despite volume declines, indicating improved operational efficiency.

Order book

  • Company has approvals in place to sell full current capacities but has not secured significant new orders recently.
  • No substantial new orders booked for the added capacity in the current fiscal year, limiting volume uptick.
  • Focus is on increasing global market share from 10% to 12% by expanding into new areas such as North America and acquiring new customers.
  • Expectation to increase capacity utilization in calendar year 2024 before considering further expansion.
  • No notable capacity expansion plans reported from peers except a Japanese competitor planning 10,000 MT expansion.
  • Demands and allocations remain key factors influencing order inflows.

How does AG Ventures rank vs peers in Chemicals & Petrochemicals?

Pro feature
1AG Ventures
Rev 4Mar 3

See full Chemicals & Petrochemicals sector rankings

How does AG Ventures rank in Chemicals & Petrochemicals?

Compare AG Ventures against every Chemicals & Petrochemicals company (Q2 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Others in Chemicals & Petrochemicals this season

  • Sudarshan Chem. (Q1 FY27)

    The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…

  • Indo Borax & Ch. (Q1 FY27)

    250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…

  • SRF (Q1 FY27)

    Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…

  • Deepak Fertilis. (Q1 FY27)

    Long-term demand-supply balance looks stable with 6-7% market growth, supporting sustained revenues despite new capacity additions. Key concall takeaways from…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →